| |
|
|
|
Fennec Pharmaceuticals Inc.  
|
|
4.26 0.26 (0.07%) |
06-18 16:00 |
|
Open: |
4.0891 |
Pre close: |
4 |
Target:
|
5.29 
|
|
High: |
4.53 |
Low: |
4.045 |
Resistance:
|
4.53
5.29
|
|
Volume: |
169,175 |
Market Cap: |
85M |
Support:
|
3.74
3.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.85
|
MACD |
MACD(12,26):
|
-0.10 |
|
MA(20): |
3.82 |
Signal(12,26,9): |
-0.18 |
|
MA(100): |
5.25  |
Stochastic Oscillator |
%K(14,3):
|
78.67 |
|
MA(250): |
6.98 |
%D(3): |
64.22 |
|
Average Volume(K) |
3-Month: |
8010
|
52-Week |
High:
|
11.81 |
|
10-Days: |
10558 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
58.60 |
Change(%): |
-61.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.520 |
Return on Equity (ttm) |
-51.4 |
Shares Out. (M) |
19.90 |
|
EPS Est. Current Year |
-0.230 |
Return on Assets (ttm) |
-48.5 |
Shares Float (M) |
19.90 |
|
EPS Est. Next Year |
-0.210 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
64.10 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.090 |
EBITDA (p.s.) |
0.000 |
P/E |
-8.19 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.58 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.70 |
P/CF |
-9.88 |
|
|
|
|
|
|
